Donald Trump Files Lawsuit Against Dominican Republic Resort

Business mogul Donald Trump has filed a lawsuit against a group of real estate developers in the Dominican Republic.

The Apprentice star has launched a $ 5.8 million legal battle against bosses at Cap Cana S.A. over allegations they failed to pay his firm, Trump Marks, licensing fees for using his name at their Trump at Capa Cana luxury…

Google’s Motorola files new suit against Apple

Google’s Motorola Mobility division has filed a lawsuit against Apple alleging that features in the Cupertino, Calif.-based company’s devices infringe on its patents.

According to Bloomberg, the company filed the lawsuit with the International Trade Commission and it includes a request for a ban on imports of the iPhone, iPad and Mac computers.

Gary Dourdan Sues Bank, Files Injunction To Stop Home Foreclosure

Former CSI: Crime Scene Investigation star Gary Dourdan has filed an injunction to stop the foreclosure of his California home.

Bankers at Wells Fargo are set to claim the actor’s Venice mansion on August 30 after he fell behind on his payments, but now the 45 year old has made a last-ditch attempt to stop the house from being sold off…

Its Official:Heidi Klum files for divorce from Seal in LA court

German model Heidi Klum and her husband singer Seal at the 63rd annual have filed for divorce. Picture: AFP HEIDI Klum has filed for divorce from singer husband Seal to end their marriage of nearly…

Oramed files provisional patent application with USPTO for combination diabetes therapy

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed a provisional patent application with the United States Patent and Trademark Office for a combination therapy of its lead compound, ORMD-0801 in combination with its oral exenatide formulation, ORMD-0901. There is no such approved combination product available on the market today.

The complexity of the development and progression of diabetes often requires…

Perrigo files ANDA and confirms Astepro Nasal Spray patent challenge

Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc. (Nasdaq: IPXL), who will share costs and benefits of this project.

On…